Journal of Parkinsons Disease

Papers
(The TQCC of Journal of Parkinsons Disease is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
A framework to standardize gait study protocols in Parkinson's disease101
This is NOT the End for Immunotherapy in Parkinson’s Disease – A Perspective from Early Drug Development Scientists82
Clinical Trial Highlights: Modulators of Mitochondrial Function71
Introduction: The Earliest Phase of Parkinson’s Disease: Possibilities for Detection and Intervention63
One-year practice effects predict long-term cognitive outcomes in Parkinson's disease53
Chronotropic Incompetence in Parkinson’s Disease: A Possible Marker of Severe Disease Phenotype?53
Glucocerebrosidase Activity is Reduced in Cryopreserved Parkinson’s Disease Patient Monocytes and Inversely Correlates with Motor Severity51
Parkinson’s Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson’s Disease Progression51
Imaging Biomarkers in Prodromal and Earliest Phases of Parkinson’s Disease50
May Bradykinesia Features Aid in Distinguishing Parkinson’s Disease, Essential Tremor, And Healthy Elderly Individuals?49
A possible pathway to freezing of gait in Parkinson's disease44
The fixel GI Parkinson's research and integrated support model (PRISM)44
A Multisensory Deficit in the Perception of Pleasantness in Parkinson’s Disease43
Early-Onset Parkinson’s Disease: Creating the Right Environment for a Genetic Disorder43
Predictive Value of Verbatim Parkinson’s Disease Patient-Reported Symptoms of Postural Instability and Falling41
Clinical Trial Highlights – Aerobic Exercise for Parkinson’s Disease39
Is There an Association Between Parkinson’s Disease and Periodontitis? A Systematic Review and Meta-Analysis39
Cerebral Small Vessel Disease Is Associated with Motor, Cognitive, and Emotional Dysfunction in Multiple System Atrophy39
Jellinger K, “Parkinson’s Disease and Dementia with Lewy Bodies: One and the Same”38
Cost-Effectiveness and Cost-Utility of Early Levodopa in Parkinson’s Disease38
Ethical Considerations for Identifying Individuals in the Prodromal/Early Phase of Parkinson’s Disease: A Narrative Review38
Reply to the Letter to the Editor: Stefani A, “Is it too early to Underrate Genetic onto PD Pathogenesis? Reflections on History”37
Effects of Very Low- and High-Frequency Subthalamic Stimulation on Motor Cortical Oscillations During Rhythmic Lower-Limb Movements in Parkinson’s Disease Patients37
Post-Traumatic Stress Disorder and Risk of Parkinson’s Disease in a Veteran Cohort37
Evading the Immune System: Immune Modulation and Immune Matching in Cell Replacement Therapies for Parkinson’s Disease36
Atrophy-related corticospinal changes in advanced Parkinson's disease are associated with the genetic etiology of the disease36
Rapid Voluntary Blinking as a Clinical Marker of Parkinson’s Disease35
Real-World Evaluation of the Feasibility, Acceptability and Safety of a Remote, Self-Management Parkinson’s Disease Care Pathway: A Healthcare Improvement Initiative35
The Role of Microelectrode Recording and Stereotactic Computed Tomography in Verifying Lead Placement During Awake MRI-Guided Subthalamic Nucleus Deep Brain Stimulation for Parkinson’s Disease34
Apathy Reflects Extra-Striatal Dopaminergic Degeneration in de novo Parkinson’s Disease34
No Higher Risk-Seeking Tendencies or Altered Self-Estimation in a Social Decision-Making Task in Patients with Parkinson’s Disease34
Are Preformed Fibrils a Model of Parkinson’s Disease?34
Blood and Cerebrospinal Fluid Biomarkers of Inflammation in Parkinson’s Disease33
Current Update on Clinically Relevant Sleep Issues in Parkinson’s Disease: A Narrative Review33
A Coalition to Advance Treatments for Parkinson’s Disease, Dementia with Lewy Bodies, and Related Disorders33
Localized Pantothenic Acid (Vitamin B5) Reductions Present Throughout the Dementia with Lewy Bodies Brain32
The Role of Diet in Parkinson’s Disease32
Metabotropic Glutamate Receptor 4 (mGlu4) Positive Allosteric Modulators Lack Efficacy in Rat and Marmoset Models of L-DOPA-Induced Dyskinesia32
The Human Hippocampus in Parkinson’s Disease: An Integrative Stereological and Proteomic Study31
Neuroinflammation and Immune Changes in Prodromal Parkinson’s Disease and Other Synucleinopathies30
Video-Based Analyses of Parkinson’s Disease Severity: A Brief Review30
The Compound ATH434 Prevents Alpha-Synuclein Toxicity in a Murine Model of Multiple System Atrophy29
DNA Methylation Signature of Aging: Potential Impact on the Pathogenesis of Parkinson’s Disease27
Gene Therapy to Modulate Alpha-Synuclein in Synucleinopathies27
Burden of tremor in Parkinson's disease: A survey study27
Burden, Anxiety, and Depression Among Caregivers of Parkinson’s Disease Patients26
Nomogram to Predict the Probability of Functional Dependence in Early Parkinson’s Disease26
Taste Impairments in a Parkinson’s Disease Model Featuring Intranasal Rotenone Administration in Mice26
Nigral Iron Deposition Influences Disease Severity by Modulating the Effect of Parkinson’s Disease on Brain Networks26
Nomogram for Early Prediction of Parkinson’s Disease Based on microRNA Profiles and Clinical Variables25
Sex-Related Longitudinal Change of Motor, Non-Motor, and Biological Features in Early Parkinson’s Disease25
Modulation of Cerebellar Oscillations with Subthalamic Stimulation in Patients with Parkinson’s Disease24
Association of Dynamic Changes in Metabolic Syndrome Status with the Risk of Parkinson’s Disease: A Nationwide Cohort Study24
Deficient Interhemispheric Connectivity Underlies Movement Irregularities in Parkinson’s Disease24
Metabolic connectivity of freezing in Parkinson's disease24
Acknowledgment to Reviewers 202223
Surveying Global Availability of Parkinson’s Disease Treatment23
Domotics, Smart Homes, and Parkinson’s Disease23
Feasibility and Proof-of-Concept of Delivering an Autonomous Music-Based Digital Walking Intervention to Persons with Parkinson’s Disease in a Naturalistic Setting23
Neuropsychiatric Burden Is a Predictor of Early Freezing and Motor Progression in Drug-Naïve Parkinson’s Disease22
Hidden Gems in Neurology: The Syndrome of Hemiparkinsonism-Hemiatrophy22
Do Impulse Control Disorders Impair Car Driving Performance in Patients with Parkinson’s Disease?22
Effects of 6 months of endurance exercise on motor function, exercise capacity, and autonomic function based on presence of autonomic dysfunction in individuals with early Parkinson's disease21
Barriers to Vaccination Among People with Parkinson’s Disease and Implications for COVID-1921
Gait Declines Differentially in, and Improves Prediction of, People with Parkinson’s Disease Converting to a Freezing of Gait Phenotype21
Bringing Advanced Therapies for Parkinson’s Disease to the Clinic: The Scientist’s Perspective21
Locus Coeruleus Degeneration Correlated with Levodopa Resistance in Parkinson’s Disease: A Retrospective Analysis21
Blood Cholesterol Decreases as Parkinson’s Disease Develops and Progresses21
Specific Detection of Physiological S129 Phosphorylated α-Synuclein in Tissue Using Proximity Ligation Assay20
Prevalence of Prodromal Symptoms of Parkinson’s Disease in the Late Middle-Aged Population20
Motor Memory Consolidation Deficits in Parkinson’s Disease: A Systematic Review with Meta-Analysis20
Effects of Low-Intensity Vestibular Noise Stimulation on Postural Instability in Patients with Parkinson’s Disease20
Recruitment for Remote Decentralized Studies in Parkinson’s Disease19
Symmetric and Profound Monoaminergic Degeneration in Parkinson’s Disease with Premotor REM Sleep Behavior Disorder19
Incretin Mimetics Restore the ER-Mitochondrial Axis and Switch Cell Fate Towards Survival in LUHMES Dopaminergic-Like Neurons: Implications for Novel Therapeutic Strategies in Parkinson’s Disease18
Freezing of gait detection: The effect of sensor type, position, activities, datasets, and machine learning model18
“Tip-of-the-Tongue” Phenomenon in Parkinson’s Disease: A Hidden Gem18
Parkinson’s Pals: A Student-Led Program to Facilitate Intergenerational Connections and Promote Psychosocial Well-Being Among Persons with Parkinson’s Disease18
Multiple Pathways of LRRK2-G2019S/Rab10 Interaction in Dopaminergic Neurons18
Non-Pharmacological Interventions for People with Parkinson’s Disease: Are We Entering a New Era?18
Specialized Allied Health Care for Parkinson’s Disease: State of the Art and Future Directions18
Enhancing Participant Engagement in Clinical Studies: Strategies Applied in the Personalized Parkinson Project18
A Summary of Phenotypes Observed in the In Vivo Rodent Alpha-Synuclein Preformed Fibril Model18
Structural-Functional Correlates of Response to Pedunculopontine Stimulation in a Randomized Clinical Trial for Axial Symptoms of Parkinson’s Disease18
Evaluating the Psychometric Properties of the Psychological Capital Questionnaire (PCQ) in Patients with Parkinson’s Disease18
Validating a Seated Virtual Reality Threat Paradigm for Inducing Anxiety and Freezing of Gait in Parkinson’s Disease17
Subcortical Iron Accumulation Pattern May Predict Neuropsychological Outcomes After Subthalamic Nucleus Deep Brain Stimulation: A Pilot Study17
Integrating virtual reality into multidisciplinary care for Parkinson's disease: A narrative review16
Enhancing Trial Delivery in Parkinson’s Disease: Qualitative Insights from PD STAT16
Staging Parkinson’s Disease According to the MNCD (Motor/Non-motor/Cognition/Dependency) Classification Correlates with Disease Severity and Quality of Life16
Disease-Modifying Therapies for Multiple System Atrophy: Where Are We in 2022?16
Self-Reported Visual Complaints in People with Parkinson’s Disease: A Systematic Review16
Parkinson’s Disease and the Gut: Symptoms, Nutrition, and Microbiota15
The Utility of Breath Analysis in the Diagnosis and Staging of Parkinson’s Disease15
Designing the First Trials for Parkinson’s Prevention15
Tackling Parkinson’s Disease as a Global Challenge15
Smartphones for Remote Symptom Monitoring of Parkinson’s Disease15
Neuroticism, Smoking, and the Risk of Parkinson’s Disease15
Enhancing the diagnostic potential of electroretinography in Parkinson's disease: A review of protocol and cohort criteria15
Neurodegeneration of the Globus Pallidus Internus as a Neural Correlate to Dopa-Response in Freezing of Gait15
Remote Delivery of Allied Health Therapies in Parkinson’s Disease14
Gender Distribution in Deep Brain Stimulation for Parkinson’s Disease: The Effect of Awake versus Asleep Surgery14
Feasibility and acceptability of PDConnect, a multi-component intervention to support physical activity in people with Parkinson's disease: A mixed methods study14
Tetrabenazine Mitigates Aberrant Release and Clearance of Dopamine in the Nigrostriatal System, and Alleviates L-DOPA-Induced Dyskinesia in a Mouse Model of Parkinson’s Disease14
Trichloroethylene: An Invisible Cause of Parkinson’s Disease?14
Non-Motor Features of Parkinson’s Disease in Women14
Which Neuropsychological Tests? Predicting Cognitive Decline and Dementia in Parkinson’s Disease in the ICICLE-PD Cohort14
Non-Pharmacological Treatment of Autonomic Dysfunction in Parkinson’s Disease and Other Synucleinopathies14
A Practical Guide to the Evaluation of Compensation Strategies for Gait Impairment in Parkinson’s Disease14
40-Year Incidence of Early-Onset Parkinson’s Disease in Southeast Minnesota14
Reduced Thickness of the Retina in de novo Parkinson’s Disease Shows A Distinct Pattern, Different from Glaucoma14
Alterations in Self-Aggregating Neuropeptides in Cerebrospinal Fluid of Patients with Parkinsonian Disorders14
Anxiety in Parkinson’s Disease Is Associated with Changes in Brain Structural Connectivity14
Serum Neurofilament Dynamics Predicts Cognitive Progression in de novo Parkinson’s Disease14
Emerging Role of Environmental Epitranscriptomics and RNA Modifications in Parkinson’s Disease14
Kinematic Effects of Combined Subthalamic and Dorsolateral Nigral Deep Brain Stimulation in Parkinson’s Disease14
Quantitative Susceptibility Mapping and Free Water Imaging of Substantia Nigra in Parkinson’s Disease14
Bringing Advanced Therapy Medicinal Products (ATMPs) for Parkinson’s Disease to the Clinic: The Investigator’s Perspective13
Prevalence of Concomitant Pathologies in Parkinson’s Disease: Implications for Prognosis, Diagnosis, and Insights into Common Pathogenic Mechanisms13
Non-Motor Symptom Management: Insights into Adherence to Treatment Guidelines in Parkinson’s Disease Patients13
Neuroimaging Correlates of Substantia Nigra Hyperechogenicity in Parkinson’s Disease13
Distinct Patterns of Gene Expression Changes in the Colon and Striatum of Young Mice Overexpressing Alpha-Synuclein Support Parkinson’s Disease as a Multi-System Process13
Self-Perception of Voice and Swallowing Handicap in Parkinson’s Disease13
Natural Health Products for Symptomatic Relief of Parkinson’s Disease: Prevalence, Interest, and Awareness13
Fatigue in de novo Parkinson’s Disease: Expanding the Neuropsychiatric Triad?13
Advice to People with Parkinson’s in My Clinic: Orthostatic Hypotension13
Can People with Parkinson’s Disease Self-Trigger Gait Initiation? A Comparison of Cueing Strategies13
Spinal Cord Stimulation for Gait Disorders in Parkinson’s Disease13
Body-Worn Sensors for Remote Monitoring of Parkinson’s Disease Motor Symptoms: Vision, State of the Art, and Challenges Ahead13
Inflammasome Activation in Parkinson’s Disease13
Longitudinal Cohort Study of Verbatim-Reported Postural Instability Symptoms as Outcomes for Online Parkinson’s Disease Trials12
Association Between Body Mass Index Changes and All-Cause Mortality in Parkinson’s Disease12
Immunological Features of LRRK2 Function and Its Role in the Gut-Brain Axis Governing Parkinson’s Disease12
Pediatric-onset PRKN disease: New insights into an understudied population12
Biofluid Detection of Pathological α-Synuclein in the Prodromal Phase of Synucleinopathies12
Non-Pharmacological Interventions for Depression and Anxiety in Parkinson’s Disease12
Assessing the Role of Locus Coeruleus Degeneration in Essential Tremor and Parkinson’s Disease with Sleep Disorders12
The Role of Pathogens and Anti-Infective Agents in Parkinson’s Disease, from Etiology to Therapeutic Implications12
Risk of Neurodegeneration in Patients with Rapid Eye Movement Sleep Behavior Disorder12
New insights from a Malaysian real-world deep brain stimulation cohort12
Return on Investment Analysis for the Integrated Parkinson’s Care Network: Lesson Learned from a Pilot Study12
Impaired Inhibitory Control During Walking in Parkinson’s Disease Patients: An EEG Study12
Therapeutic Strategies for Immune Transformation in Parkinson’s Disease12
Pain Fluctuations in Parkinson’s Disease and Their Association with Motor and Non-Motor Fluctuations12
Mycobacterium bovis Infection of a Deep Brain Stimulation System Following Intravesical Bacillus Calmette-Guérin (BCG) Instillation12
Constipation Predicts Cognitive Decline in Parkinson’s Disease: Results from the COPPADIS Cohort at 2-Year Follow-up and Comparison with a Control Group12
The Use of Image Guided Programming to Improve Deep Brain Stimulation Workflows with Directional Leads in Parkinson’s Disease12
RAGE Against the Glycation Machine in Synucleinopathies: Time to Explore New Questions12
Dopaminergic Cell Replacement for Parkinson’s Disease: Addressing the Intracranial Delivery Hurdle11
Structural Connectivity of Subthalamic Nucleus Stimulation for Improving Freezing of Gait11
Why the Gut Microbiome Must Be Considered When Evaluating the Impact of Pesticides on Parkinson’s Disease Risk11
Machine Learning-Based Classification of Parkinson’s Disease Patients Using Speech Biomarkers11
Hypomimia May Influence the Facial Emotion Recognition Ability in Patients with Parkinson’s Disease11
Worsening of Parkinson’s Disease After Termination of COVID-19 Quarantine Cannot Be Reversed Despite Resumption of Physiotherapy11
How Information Affects Patients with Parkinson’s Disease: A Scoping Review of the Literature11
Mapping Cholinergic Synaptic Loss in Parkinson’s Disease: An [18F]FEOBV PET Case-Control Study11
Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2021 Update11
Integration of Virtual Reality into Transcranial Magnetic Stimulation Improves Cognitive Function in Patients with Parkinson’s Disease with Cognitive Impairment: A Proof-of-Concept Study11
Modeling of Parkinson’s Disease Progression and Implications for Detection of Disease Modification in Treatment Trials11
Letter to the Editor: Is It Too Early to Underrate Genetics onto PD Pathogenesis? Reflections on History11
Glucocerebrosidase Mutations and Motor Reserve in Parkinson’s Disease11
Personality Changes After Subthalamic Nucleus Stimulation in Parkinson’s Disease11
Appropriateness of Applying Cerebrospinal Fluid Biomarker Cutoffs from Alzheimer’s Disease to Parkinson’s Disease11
Axial Impairment Following Deep Brain Stimulation in Parkinson’s Disease: A Surgicogenomic Approach11
PTEN-Induced Putative Kinase 1 Dysfunction Accelerates Synucleinopathy11
Comparative Analysis of Total Alpha-Synuclein (αSYN) Immunoassays Reveals That They Do Not Capture the Diversity of Modified αSYN Proteoforms11
Efficacy of Istradefylline, an Adenosine A2A Receptor Antagonist, as Adjunctive Therapy to Levodopa in Parkinson’s Disease: A Pooled Analysis of 8 Phase 2b/3 Trials11
Preparing for Parkinson’s disease prevention trials: Current progress and future directions11
Diffusion MRI Captures White Matter Microstructure Alterations in PRKN Disease11
Acknowledgment to Reviewers 202311
Infections and Changes in Commensal Bacteria and the Pathogenesis of Parkinson’s Disease11
The potential of distributed diagnostics for the early detection of Parkinson's disease11
Constipation is Associated with Development of Cognitive Impairment in de novo Parkinson’s Disease: A Longitudinal Analysis of Two International Cohorts10
Foslevodopa/Foscarbidopa Is Well Tolerated and Maintains Stable Levodopa and Carbidopa Exposure Following Subcutaneous Infusion10
Colonoscopy and Subsequent Risk of Parkinson’s Disease10
Dengue Virus Infection and Risk of Parkinson’s Disease: A Nationwide Longitudinal Study10
Development of a Screening Tool for Assessing Sexual Difficulties Among Patients with Parkinson’s Disease: The PD-SDS10
Insights on Genetic and Environmental Factors in Parkinson’s Disease from a Regional Swedish Case-Control Cohort10
Screening Tools for Sarcopenia in Mild to Moderate Parkinson’s Disease: Assessing the Accuracy of SARC-F and Calf Circumference10
Parkinson's disease participant-led research on the impact of deep brain stimulation frequency10
Data Protection Using Polymorphic Pseudonymisation in a Large-Scale Parkinson’s Disease Study10
Concordance between imaging and clinical based STN-DBS programming improves motor outcomes of directional stimulation in Parkinson's disease10
Using Extracellular miRNA Signatures to Identify Patients with LRRK2-Related Parkinson’s Disease10
Characterization of Depressive and Anxiety Symptoms in Idiopathic REM Sleep Behavior Disorder10
Reaching and Grasping Movements in Parkinson’s Disease: A Review10
Increasing trends in utilization of physical and occupational therapy services in early Parkinson's disease10
Oscillation-Specific Nodal Differences in Parkinson’s Disease Patients with Anxiety10
Retrograde Procedural Memory in Parkinson’s Disease: A Cross-Sectional, Case-Control Study10
Disease Progression of Data-Driven Subtypes of Parkinson’s Disease: 5-Year Longitudinal Study from the Early Parkinson’s Disease Longitudinal Singapore (PALS) Cohort10
0.19212198257446